Skip to main content
Premium Trial:

Request an Annual Quote

Venter Center Reorg Topped Most-Read GenomeWeb Daily News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, April 13.
1. Venter Center Breaks Up TIGR and TCAG Into 10 Research Units, Shuffles Brass (from April 12)
2. Ciphergen Has 'Substantial Doubts' About Its Ability to Stay in Business; May Need to Raise Cash to Stay Afloat (from April 10)
3. Mount Sinai to Start Personalized Medicine Institute With $12.5M Seed Grant (from April 9)
4. Illumina to Shutter Connecticut Facility That Builds BeadXpress, Will Consolidate in San Diego (from April 11)
5. Qiagen to Buy eGene in $34M Cash and Stock Deal (from April 13)
The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.